Author Archives: admin

Meatless diets are a bad idea

April 29, 2024- by Steven E. Greer, MD

Posted in - Opinion, - Policy, - Reviews, books, devices, Cardiac surgery, Cardiology, Geriatrics, Oncology, Pediatrics, Sports medicine | Leave a comment

Infectious diseases killed three out of four of Lincoln’s sons

April 8, 2024- by Steven E. Greer, MD

Posted in - Opinion, Infectious disease | Leave a comment

Ten years later: The urgent care trend.

January 31, 2024- by Steven E. Greer, MD It was 10-years ago that I was on the forefront of the “urgent care” trend. There were very few privately-owned ER’s at the time. Anyone needing care had to wait many hours at … Continue reading

Posted in Uncategorized | Leave a comment

A Surgeon’s Story: Decision-making

March 16, 2024- by Steven E. Greer, MD Here is a general surgery story for you.

Posted in - Opinion, General surgery | 2 Comments

mRNA vaccine boosters and impaired immune system response

February 3, 2024- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, CDC, Congress, FDA, Infectious disease | Leave a comment

I have failed as a paid doctor

January 26, 2024- by Steven E. Greer, MD I was listening to music last night when I had a random thought. I chuckled to myself at the absurdly high level of care that I give to my medical patients.

Posted in - Opinion | Leave a comment

Hospitals made out like bandits during the COVID pandemic

August 6, 2023- by Steven Greer, MD

Posted in Uncategorized | Leave a comment

Steven E. Greer MD: A discussion with Bill O’Reilly about radiation risks

April 1, 2011- A discussion with Bill O’Reilly about radiation risks from the Fukushima nuclear meltdowns and the fallout hitting the U.S. and entire globe.

Posted in - Policy, Congress, NYU, Ohio State, Oncology | Leave a comment

Any type of coronavirus vaccine (i.e., gene therapy) that uses the spike-protein will be deadly

February 20, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, FDA | Leave a comment

Interview with drug trials expert Sasha Latypova on how the COVID vaccine approvals were a sham

July 7, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, FDA, Infectious disease, NIH | Leave a comment

Paxlovid causes rebound COVID 25% of the time

January 7, 2024- by Steven E. Greer, MD

Posted in - Pharma, CDC, Emergency medicine, Infectious disease | Leave a comment

Putrid food of the 19th Century

November 29, 2023- by Steven E. Greer, MD I have been watching a 48-part lecture by a University of Virginia historian on the Civil

Posted in - Opinion, - Reviews, books, devices, Bariatric surgery, FDA | Leave a comment

The slippery slope of stifling free speech

December 10, 2023- by Steven E. Greer, MD

Posted in - Opinion, - Policy | Leave a comment

Oral arguments in Cortex Television v. New York State Dept Health, Index No. 318612 (Sup. Ct., Albany Cnty. 2022)

October 18, 2023

Posted in - Policy | Leave a comment

How to establish a face transplant team

Update December 1, 2018- Dr. Rodriguez and his team of at least 100 surgeons, psychiatrists, social

Posted in - Policy, NYU, Plastic surgery | Leave a comment

Exclusive: The gender reassignment butchers have taken over my NYU surgery

September 5, 2023- by Steven E. Greer, MD Opinion-

Posted in - Opinion, CMS, Congress, Obstetrics and Gynecology, Pediatrics, Plastic surgery, Primary care medicine, Psychology Psychiatry | 1 Comment

The long and winding road of the Ventilator Death paper (Perseverance Prevails)

November 1, 2023- by Steven E. Greer, MD

Posted in - JAMA, - Medical Devices, - Opinion, - Policy | Leave a comment

Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity

September 1, 2023- by Sucharit Bhakdi, MD et al

Posted in - Biotech, - Pharma, - Reviews, books, devices, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology, Pediatrics | Leave a comment

Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)

Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.

Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease | Leave a comment

Ivermectin works against COVID in double blind, randomized, controlled trial

May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.

Posted in - Biotech, - Generics, - Pharma, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine | Leave a comment